First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Genmab
Genmab
IGM Biosciences, Inc.
MingSight Pharmaceuticals, Inc
Altor BioScience
Sunesis Pharmaceuticals
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
National Cancer Institute (NCI)